14 February 2026 (Saturday)
14 February 2026 (Saturday)
Business News

Fineotex Chemical Results 2026: Explosive 45% Revenue Growth and ₹3,012 Lakh PAT Boost Performance

Fineotex Chemical
Email :

Fineotex Chemical delivered a strong Q3 FY26 with 45% YoY revenue growth and ₹3,012 lakh consolidated PAT. The specialty chemical major also completed a strategic U.S. acquisition, strengthening its global expansion strategy.


Author: Aditya Pareek | EQMint


Specialty chemicals manufacturer Fineotex Chemical Limited has reported robust Fineotex Chemical Q3 results for the quarter ended 31 December 2025.


As per the official filing submitted to BSE and NSE, the Board approved the unaudited standalone and consolidated financial results on February 13, 2026 4.


The results reflect strong operational execution, improved margins, and strategic global expansion.


Revenue Growth: 45% YoY Surge

One of the biggest highlights of the Fineotex Chemical Q3 results is the sharp increase in consolidated revenue.


Q3 FY26 (Consolidated – YoY Basis)

  • Total Income from Operations: ₹19,046 lakh
  • Previous Year Q3: ₹13,091 lakh
  • Revenue Growth: 45.49% YoY

On a QoQ basis, revenue grew 30.96%, showcasing accelerating business momentum.

This significant Fineotex Chemical revenue growth demonstrates expanding demand across domestic and international markets.


Profitability: Consolidated PAT at ₹3,012 Lakh

Profit performance remained strong.


Q3 FY26 Consolidated Numbers:

  • EBITDA: ₹3,484 lakh
  • EBITDA Growth (QoQ): 12.28%
  • Fineotex Chemical consolidated PAT: ₹3,012 lakh
  • PAT Growth (YoY): 8.23%

The company maintained operational efficiency despite global volatility.

Nine-month PAT stood at ₹8,122 lakh, reinforcing strong Fineotex Chemical FY26 earnings momentu.


Return on Invested Capital (ROIC) at 26.82%

The company reported consolidated ROIC of 26.82% for Q3 FY26, indicating:

Efficient capital allocation
Strong operational returns
High-quality earnings


For investors tracking Fineotex Chemical share news, this ROIC level signals disciplined financial management.


Strategic U.S. Acquisition: CrudeChem Technologies

A key strategic highlight in the Fineotex Chemical Q3 results was the successful acquisition of U.S.-based specialty chemical manufacturer CrudeChem Technologies (CCT Group) through its subsidiary 4.


CrudeChem operates in:

  • Advanced chemical fluid additives
  • Oilfield chemical solutions
  • Global oil & gas sector

This acquisition strengthens:

  • Technological capabilities
  • Global footprint
  • Sustainable chemical innovation

The move positions Fineotex as a more diversified global specialty chemical player.


Volume Growth: 39% YoY Increase

Volume expansion remained strong.


The consolidated business recorded approximately 39% YoY volume growth during the quarter 4.


This confirms that Fineotex Chemical revenue growth was supported by both pricing strength and volume expansion.


Capital Structure Developments

The company undertook several corporate actions:

  • Sub-division of shares (₹2 to ₹1 face value)
  • 4:1 bonus issue
  • Conversion of warrants into equity
  • Paid-up capital increased to ₹11,595.01 lakh

Additionally, 75% of outstanding warrants were converted, bringing ₹35.68 crore subscription inflow 4.


These moves improved liquidity and strengthened equity base.


Standalone Performance Snapshot

Q3 FY26 Standalone

  • Revenue: ₹9,647 lakh
  • PAT: ₹2,565 lakh
  • EPS: ₹0.22

Nine-month standalone PAT stood at ₹7,075 lakh.


The standalone business remains stable while consolidated performance reflects global expansion impact.


Auditor’s Review

The consolidated and standalone financial statements were subjected to Limited Review by statutory auditors, who issued an unqualified report 4.


This strengthens credibility in Fineotex Chemical FY26 earnings reporting.


Outlook: Specialty Chemicals Growth Story Intact

Fineotex continues to benefit from:

  • Rising global demand for specialty chemicals
  • Export growth
  • Oil & gas sector exposure
  • Technological expansion via acquisitions

With improving volumes, strong ROIC, and global footprint expansion, the outlook for Fineotex Chemical share news remains constructive.


Conclusion

The latest Fineotex Chemical Q3 results highlight:

45% revenue growth
₹3,012 lakh consolidated PAT
39% volume growth
26.82% ROIC
Strategic U.S. acquisition


The company’s strong Fineotex Chemical revenue growth and improving Fineotex Chemical consolidated PAT reinforce its position as a fast-growing specialty chemical player in FY26.


Investors tracking Fineotex Chemical FY26 earnings will closely watch upcoming quarters for margin sustainability and integration benefits from CrudeChem acquisition.


For more such information visit EQMint


Source link: BSE


Disclaimer:  This article is not an investment advice and is for educational purpose only.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

eqmint